Bio & Pharma
CJ CheilJedang invests in Australian bio startup
The food and bio company seeks to boost green technology through microorganisms and microalgae
By Mar 02, 2023 (Gmt+09:00)
1
Min read
Most Read
LG Chem to sell water filter business to Glenwood PE for $692 million


KT&G eyes overseas M&A after rejecting activist fund's offer


Kyobo Life poised to buy Japan’s SBI Group-owned savings bank


StockX in merger talks with Naver’s online reseller Kream


Meritz backs half of ex-manager’s $210 mn hedge fund



South Korea's food and bio company CJ CheilJedang Corp. on Wednesday said it will invest in the Australian bio startup Provectus Algae.
The former seeks to create synergy through the combination of the microbial fermentation technology capacity of its bio unit with the latter’s mass production know-how in microalgae.
Founded in 2018, Provectus Algae boasts the technology to cultivate microalgae for use in the development of high value-added materials such as food coloring and pharmaceutical peptides.
The investment amount was not disclosed.
Microalgae, also called phytoplankton, absorbs carbon dioxide and conducts photosynthesis. The sugar produced at this time is stored as lipids and starch within cells, and this enables production of substances for use as fuel and materials while reducing CO2.
Write to Jiyoon Yang at yang@hankyung.com
More to Read
-
Bio & PharmaCJ CheilJedang to strengthen R&D for bio and healthcare businesses
Nov 08, 2022 (Gmt+09:00)
1 Min read -
Mergers & AcquisitionsCJ Cheiljedang to acquire Dutch bio firm Batavia for 195 million euros
Nov 08, 2021 (Gmt+09:00)
2 Min read
Comment 0
LOG IN